Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthma

The American Journal of Medicine

Volumn 97, Issue 1, 1994, Pages 29-37

  Newnham, Donald M ^a   McDevitt, Denis G ^a   Lipworth, Brian J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BRONCHODILATING AGENT; FORMOTEROL; IPRATROPIUM BROMIDE; PLACEBO; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; DOSE RESPONSE; DRUG SENSITIVITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LYMPHOCYTE FUNCTION; MALE; PRIORITY JOURNAL; TACHYPHYLAXIS;

ADRENERGIC BETA-AGONISTS; ADULT; ANALYSIS OF VARIANCE; ASTHMA; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG TOLERANCE; ETHANOLAMINES; FEMALE; HUMAN; IN VITRO; LYMPHOCYTES; MALE; MIDDLE AGE; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATION; RESPIRATORY FUNCTION TESTS;

EID: 0028287832     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(94)90045-0     Document Type: Article

References (32)

1. Bronchodilator effect of inhaled formoterol versus salbutamol over 12 hours
2. 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction
3. Formoterol aerosol: a dose-finding trial with regard to duration of action
4. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma
5. 2-agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma
6. Inhaled salmeterol and salbutamol in asthmatic patients: an evaluation of asthma symptoms and the possible development of tachyphylaxis
7. Formoterol, a new long-acting bronchodilator for inhalation
8. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
9. Standardization of spirometry-update
10. The Q-T interval
11. An analysis of the time relations of electrocardiograms
12. Reproducibility of cardiac output measurement by cross sectional and doppler echocardiography
13. Assessment of cardiac output by the Doppler ultrasound technique alone.
14. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects
15. A comparison of salmeterol with albuterol in the treatment of mild to moderate asthma
16. 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma
17. Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol
18. 2-agonists in asthma
19. Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics
20. Assessment of tachyphylaxis following prolonged therapy with inhaled albuterol aerosol
21. Effect of intravenous prednisolone in asthmatics with diminsted adrenergic responsiveness
22. Beta-adrenergic agonist resistance in normal human airways
23. 2-bronchodilators
24. Increased bronchial hyperresponsiveness after inhaling salbutamol during one year is not caused by desensitisation to salbutamol
25. 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients
26. 2-adrenergic receptors and rhodospin: shedding new light on an old subject
27. 2-adrenergic receptor kinase
28. 2-agonists: comparison of inhaled eformoterol with salbutamol
29. Salmeterol, formoterol, and salbutamol in isolated guinea-pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism
30. Effects of formoterol in isolated human bronchus
31. 2-adrenoceptor responses in asthmatic patients taking regular low-dose inhaled salbutamol
32. 2-adrenoceptor responsiveness in patients with chronic obstructive pulmonary disease